microRNA information: hsa-miR-192-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-192-5p | miRbase |
Accession: | MIMAT0000222 | miRbase |
Precursor name: | hsa-mir-192 | miRbase |
Precursor accession: | MI0000234 | miRbase |
Symbol: | MIR192 | HGNC |
RefSeq ID: | NR_029578 | GenBank |
Sequence: | CUGACCUAUGAAUUGACAGCC |
Reported expression in cancers: hsa-miR-192-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-192-5p | breast cancer | upregulation | "We found that patients with recurrence showed high ......" | 27304060 | |
hsa-miR-192-5p | colon cancer | upregulation | "MicroRNA 192 suppresses liver metastasis of colon ......" | 24213572 | |
hsa-miR-192-5p | colorectal cancer | downregulation | "microRNA 192 194 and 215 are frequently downregula ......" | 22969930 | qPCR |
hsa-miR-192-5p | gastric cancer | downregulation | "Expression levels of microRNA 192 and 215 in gastr 0.05 paired t-test. Also the down-regulation of miR-192 and -215 was demonstrated to be associated with increased tumor sizes both p = 0.003 Mann-Whitney U test and advanced Borrmann type tumors p = 0.015 and p = 0.044 respectively Kruskal-Wallis H test. Furthermore there was a strong correlation between miR-192 and -215 in gastric cancer tissues p < 0.001 Pearson regressions. miR-192 and -215 might be related to the proliferation and invasion of gastric cancer"> ......" | 22205577 | qPCR |
hsa-miR-192-5p | gastric cancer | upregulation | "Plasma miR 122 and miR 192 as potential novel biom ......" | 24481716 | Reverse transcription PCR; qPCR |
hsa-miR-192-5p | kidney renal cell cancer | downregulation | "miR 192 miR 194 and miR 215: a convergent microRNA ......" | 23715501 | |
hsa-miR-192-5p | pancreatic cancer | upregulation | "Metformin up-regulated the expression of miR-26a m ......" | 22245693 | |
hsa-miR-192-5p | pancreatic cancer | downregulation | "Early Epigenetic Downregulation of microRNA 192 Ex ......" | 27216198 | |
hsa-miR-192-5p | retinoblastoma | downregulation | "Analysis of miRNA expression in clinical samples s ......" | 21511813 | |
hsa-miR-192-5p | sarcoma | downregulation | "However the pathophysiological role of miR-192 and ......" | 27683056 | qPCR |
Reported cancer pathway affected by hsa-miR-192-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-192-5p | bladder cancer | cell cycle pathway; Apoptosis pathway | "Regulation of growth of human bladder cancer by mi ......" | 25566965 | MTT assay; Flow cytometry; Western blot |
hsa-miR-192-5p | breast cancer | cell cycle pathway | "BMP 6 inhibits cell proliferation by targeting mic ......" | 24012720 | |
hsa-miR-192-5p | colon cancer | Apoptosis pathway | "MicroRNA 192 suppresses liver metastasis of colon ......" | 24213572 | |
hsa-miR-192-5p | gastric cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 192 and 215 are upregulated in human gast ......" | 21119604 | Western blot; Luciferase |
hsa-miR-192-5p | lung cancer | Apoptosis pathway | "MiR 192 confers cisplatin resistance by targeting ......" | 24854555 | Western blot; Luciferase |
hsa-miR-192-5p | lung squamous cell cancer | Apoptosis pathway | "Curcumin promotes apoptosis by activating the p53 ......" | 25444916 | |
hsa-miR-192-5p | lung squamous cell cancer | PI3K/Akt signaling pathway; Apoptosis pathway | "Curcumin inhibits cell proliferation and induces a ......" | 26351877 | |
hsa-miR-192-5p | ovarian cancer | cell cycle pathway | "Pro-proliferative and anti-proliferative miRNAs in ......" | 23588298 | |
hsa-miR-192-5p | pancreatic cancer | Epithelial mesenchymal transition pathway | "Early Epigenetic Downregulation of microRNA 192 Ex ......" | 27216198 | |
hsa-miR-192-5p | prostate cancer | cell cycle pathway | "MiR 192 suppresses the tumorigenicity of prostate ......" | 26743688 | Flow cytometry; Western blot; Luciferase |
hsa-miR-192-5p | retinoblastoma | Apoptosis pathway | "MicroRNA 192 targeting retinoblastoma 1 inhibits c ......" | 21511813 | |
hsa-miR-192-5p | sarcoma | Apoptosis pathway | "Upregulation of miR 192 inhibits cell growth and i ......" | 27683056 | Western blot; Luciferase |
Reported cancer prognosis affected by hsa-miR-192-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-192-5p | bladder cancer | progression | "Regulation of growth of human bladder cancer by mi ......" | 25566965 | MTT assay; Flow cytometry; Western blot |
hsa-miR-192-5p | breast cancer | progression | "BMP 6 inhibits cell proliferation by targeting mic ......" | 24012720 | |
hsa-miR-192-5p | breast cancer | drug resistance | "MiR 192 Mediated Positive Feedback Loop Controls t ......" | 26642352 | |
hsa-miR-192-5p | breast cancer | drug resistance; recurrence | "miR-192-5p induced by LY6K downregulates ERα dire ......" | 27304060 | |
hsa-miR-192-5p | colon cancer | metastasis; drug resistance; staging; progression | "MicroRNA 192 suppresses liver metastasis of colon ......" | 24213572 | |
hsa-miR-192-5p | colorectal cancer | tumor size; tumorigenesis | "microRNA 192 194 and 215 are frequently downregula ......" | 22969930 | |
hsa-miR-192-5p | colorectal cancer | poor survival | "The expression levels of miR-206 miR-219 miR-192 m ......" | 27666868 | |
hsa-miR-192-5p | colorectal cancer | staging; poor survival | "Significant inverse correlation between the expres ......" | 27747302 | |
hsa-miR-192-5p | esophageal cancer | staging; drug resistance | "MicroRNA profiling in locally advanced esophageal ......" | 23649428 | |
hsa-miR-192-5p | esophageal cancer | drug resistance | "An in-vitro model of acquired chemotherapy resista ......" | 25356050 | |
hsa-miR-192-5p | gastric cancer | cell migration | "MicroRNA 192 and 215 are upregulated in human gast ......" | 21119604 | Western blot; Luciferase |
hsa-miR-192-5p | gastric cancer | staging; tumor size | "Expression levels of microRNA 192 and 215 in gastr 0.05 paired t-test; Interestingly miR-192 and -215 were down-regulated in MGC-803 cells BGC-823 cells and SGC-7901 cells all p < 0.01 paired t-test; Also the down-regulation of miR-192 and -215 was demonstrated to be associated with increased tumor sizes both p = 0.003 Mann-Whitney U test and advanced Borrmann type tumors p = 0.015 and p = 0.044 respectively Kruskal-Wallis H test; Moreover the expression of miR-192 was significantly lower in the pT4 stage of gastric cancer than in pT1 pT2 and pT3 stages p = 0.026; Furthermore there was a strong correlation between miR-192 and -215 in gastric cancer tissues p < 0.001 Pearson regressions; miR-192 and -215 might be related to the proliferation and invasion of gastric cancer"> ......" | 22205577 | |
hsa-miR-192-5p | gastric cancer | metastasis; worse prognosis; poor survival | "Plasma miR 122 and miR 192 as potential novel biom ......" | 24481716 | |
hsa-miR-192-5p | gastric cancer | tumorigenesis | "However the role of miR-215 or miR-192 in gastric ......" | 24981590 | |
hsa-miR-192-5p | kidney renal cell cancer | progression | "miR 192 miR 194 and miR 215: a convergent microRNA ......" | 23715501 | Luciferase |
hsa-miR-192-5p | liver cancer | metastasis; worse prognosis | "MicroRNA 192 5p Promote the Proliferation and Meta ......" | 26580097 | Flow cytometry; Luciferase |
hsa-miR-192-5p | liver cancer | metastasis; cell migration; poor survival | "miR 192 a prognostic indicator targets the SLC39A6 ......" | 26684241 | |
hsa-miR-192-5p | liver cancer | worse prognosis; progression; poor survival | "To establish serum microRNA profiles as prognostic ......" | 27317768 | |
hsa-miR-192-5p | lung cancer | drug resistance | "MiR 192 confers cisplatin resistance by targeting ......" | 24854555 | Western blot; Luciferase |
hsa-miR-192-5p | lung cancer | drug resistance | "MicroRNA 192 regulates chemo resistance of lung ad ......" | 26550150 | Western blot; MTT assay |
hsa-miR-192-5p | lung squamous cell cancer | poor survival | "The 3-miRNA panel expression miR-192 miR-200c and ......" | 27153322 | |
hsa-miR-192-5p | ovarian cancer | staging | "The aim of this study was to investigate whether m ......" | 22340095 | Western blot |
hsa-miR-192-5p | pancreatic cancer | progression | "Early Epigenetic Downregulation of microRNA 192 Ex ......" | 27216198 | |
hsa-miR-192-5p | retinoblastoma | tumorigenesis | "MicroRNA 192 targeting retinoblastoma 1 inhibits c ......" | 21511813 |
Reported gene related to hsa-miR-192-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-192-5p | breast cancer | TP53 | "MiR 192 Mediated Positive Feedback Loop Controls t ......" | 26642352 |
hsa-miR-192-5p | lung squamous cell cancer | TP53 | "Curcumin promotes apoptosis by activating the p53 ......" | 25444916 |
hsa-miR-192-5p | liver cancer | AGO2 | "In the current study we identified miR-192 and miR ......" | 26710269 |
hsa-miR-192-5p | gastric cancer | ALCAM | "MicroRNA 192 and 215 are upregulated in human gast ......" | 21119604 |
hsa-miR-192-5p | lung cancer | BCL2 | "MicroRNA 192 regulates chemo resistance of lung ad ......" | 26550150 |
hsa-miR-192-5p | lung cancer | BCL2L11 | "MiR 192 confers cisplatin resistance by targeting ......" | 24854555 |
hsa-miR-192-5p | breast cancer | BMP6 | "BMP 6 inhibits cell proliferation by targeting mic ......" | 24012720 |
hsa-miR-192-5p | retinoblastoma | CASP7 | "Both caspase-7 and the PARP protein were activated ......" | 21511813 |
hsa-miR-192-5p | gastric cancer | DMPK | "Our results demonstrated that assessment of decrea ......" | 24481716 |
hsa-miR-192-5p | liver cancer | HOTTIP | "In the current study we identified miR-192 and miR ......" | 26710269 |
hsa-miR-192-5p | breast cancer | LY6K | "miR-192-5p induced by LY6K downregulates ERα dire ......" | 27304060 |
hsa-miR-192-5p | prostate cancer | MAP2K6 | "Furthermore miR-192 inhibited the expression of p3 ......" | 26743688 |
hsa-miR-192-5p | prostate cancer | NIN | "MiR 192 suppresses the tumorigenicity of prostate ......" | 26743688 |
hsa-miR-192-5p | prostate cancer | NOB1 | "Bioinformatics analysis results revealed that NOB1 ......" | 26743688 |
hsa-miR-192-5p | colorectal cancer | PER1 | "Significant inverse correlation between the expres ......" | 27747302 |
hsa-miR-192-5p | liver cancer | SEMA3A | "MicroRNA 192 5p Promote the Proliferation and Meta ......" | 26580097 |
hsa-miR-192-5p | liver cancer | SLC39A6 | "Solute carrier family 39 member 6 SLC39A6 was iden ......" | 26684241 |
hsa-miR-192-5p | liver cancer | SNAI1 | "Suppression of migration and invasion caused by mi ......" | 26684241 |
hsa-miR-192-5p | sarcoma | TCF7 | "Upregulation of miR 192 inhibits cell growth and i ......" | 27683056 |
hsa-miR-192-5p | lung squamous cell cancer | XIAP | "Curcumin promotes apoptosis by activating the p53 ......" | 25444916 |
hsa-miR-192-5p | gastric cancer | ZNF135 | "Moreover the expression of miR-192 was significant ......" | 22205577 |
hsa-miR-192-5p | gastric cancer | ZNF77 | "Moreover the expression of miR-192 was significant ......" | 22205577 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-192-5p | ABCA8 | 11 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.519; TCGA BRCA -1.007; TCGA COAD -1.025; TCGA HNSC -0.349; TCGA LUAD -0.147; TCGA LUSC -0.586; TCGA OV -0.441; TCGA PAAD -0.445; TCGA PRAD -0.379; TCGA STAD -0.489; TCGA UCEC -0.394 |
hsa-miR-192-5p | AP1S2 | 11 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.261; TCGA CESC -0.094; TCGA COAD -0.326; TCGA ESCA -0.104; TCGA LIHC -0.327; TCGA LUAD -0.079; TCGA LUSC -0.11; TCGA PAAD -0.266; TCGA THCA -0.21; TCGA STAD -0.339; TCGA UCEC -0.139 |
hsa-miR-192-5p | APOLD1 | 9 cancers: BLCA; BRCA; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.22; TCGA BRCA -0.293; TCGA LUAD -0.108; TCGA LUSC -0.19; TCGA PAAD -0.29; TCGA PRAD -0.194; TCGA SARC -0.134; TCGA STAD -0.128; TCGA UCEC -0.293 |
hsa-miR-192-5p | ARHGEF10 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUSC; OV; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.187; TCGA BRCA -0.151; TCGA COAD -0.145; TCGA HNSC -0.115; TCGA LIHC -0.424; TCGA LUSC -0.207; TCGA OV -0.116; TCGA SARC -0.272; TCGA STAD -0.174; TCGA UCEC -0.134 |
hsa-miR-192-5p | ARL2BP | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.127; TCGA CESC -0.088; TCGA COAD -0.058; TCGA ESCA -0.111; TCGA HNSC -0.146; TCGA LGG -0.085; TCGA LIHC -0.078; TCGA PAAD -0.05; TCGA PRAD -0.065; TCGA STAD -0.105; TCGA UCEC -0.092 |
hsa-miR-192-5p | ARL4C | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; OV; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.211; TCGA BRCA -0.105; TCGA CESC -0.073; TCGA COAD -0.477; TCGA ESCA -0.268; TCGA KIRP -0.308; TCGA LIHC -0.446; TCGA OV -0.1; TCGA PAAD -0.287; TCGA PRAD -0.133; TCGA THCA -0.36; TCGA STAD -0.097 |
hsa-miR-192-5p | ATP10D | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.281; TCGA BRCA -0.116; TCGA CESC -0.134; TCGA COAD -0.249; TCGA ESCA -0.203; TCGA HNSC -0.245; TCGA LIHC -0.126; TCGA LUSC -0.149; TCGA PAAD -0.138; TCGA PRAD -0.112; TCGA STAD -0.119; TCGA UCEC -0.068 |
hsa-miR-192-5p | BCL2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.209; TCGA BRCA -0.171; TCGA CESC -0.129; TCGA COAD -0.228; TCGA ESCA -0.074; TCGA LIHC -0.343; TCGA OV -0.122; TCGA PAAD -0.307; TCGA STAD -0.219; TCGA UCEC -0.31 |
hsa-miR-192-5p | BMPR2 | 11 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; OV; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.128; TCGA BRCA -0.055; TCGA COAD -0.195; TCGA HNSC -0.086; TCGA LIHC -0.075; TCGA LUAD -0.052; TCGA LUSC -0.168; TCGA OV -0.07; TCGA THCA -0.103; TCGA STAD -0.102; TCGA UCEC -0.124 |
hsa-miR-192-5p | C1QTNF3 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.283; TCGA BRCA -0.226; TCGA COAD -0.445; TCGA ESCA -0.137; TCGA HNSC -0.228; TCGA KIRC -0.119; TCGA KIRP -0.317; TCGA LGG -0.098; TCGA LUAD -0.083; TCGA LUSC -0.326; TCGA OV -0.264; TCGA PAAD -0.273; TCGA STAD -0.376; TCGA UCEC -0.133 |
hsa-miR-192-5p | CDK14 | 11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.282; TCGA BRCA -0.065; TCGA COAD -0.609; TCGA ESCA -0.198; TCGA LUAD -0.076; TCGA LUSC -0.331; TCGA OV -0.209; TCGA PAAD -0.352; TCGA THCA -0.091; TCGA STAD -0.238; TCGA UCEC -0.105 |
hsa-miR-192-5p | CFL2 | 11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.422; TCGA BRCA -0.213; TCGA COAD -0.521; TCGA ESCA -0.118; TCGA LUAD -0.099; TCGA LUSC -0.151; TCGA PAAD -0.219; TCGA PRAD -0.283; TCGA SARC -0.412; TCGA STAD -0.48; TCGA UCEC -0.223 |
hsa-miR-192-5p | CHSY3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.348; TCGA BRCA -0.13; TCGA CESC -0.158; TCGA COAD -0.412; TCGA ESCA -0.087; TCGA LIHC -0.197; TCGA LUAD -0.226; TCGA LUSC -0.269; TCGA OV -0.234; TCGA PAAD -0.308; TCGA SARC -0.161; TCGA THCA -0.292; TCGA UCEC -0.192 |
hsa-miR-192-5p | CLIP4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.401; TCGA BRCA -0.289; TCGA CESC -0.329; TCGA COAD -0.734; TCGA ESCA -0.346; TCGA HNSC -0.204; TCGA KIRC -0.118; TCGA LIHC -0.384; TCGA LUAD -0.085; TCGA PAAD -0.247; TCGA PRAD -0.338; TCGA STAD -0.422; TCGA UCEC -0.167 |
hsa-miR-192-5p | CNTNAP3 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.38; TCGA BRCA -0.452; TCGA CESC -0.383; TCGA COAD -0.886; TCGA ESCA -0.371; TCGA LUSC -0.206; TCGA PAAD -0.328; TCGA PRAD -0.357; TCGA SARC -0.425; TCGA STAD -0.526 |
hsa-miR-192-5p | CORO2B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.237; TCGA BRCA -0.524; TCGA CESC -0.158; TCGA COAD -0.65; TCGA ESCA -0.07; TCGA KIRC -0.205; TCGA LIHC -0.369; TCGA LUAD -0.086; TCGA LUSC -0.388; TCGA PAAD -0.323; TCGA PRAD -0.234; TCGA STAD -0.318; TCGA UCEC -0.362 |
hsa-miR-192-5p | DCBLD2 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.2; TCGA BRCA -0.105; TCGA COAD -0.383; TCGA ESCA -0.35; TCGA KIRC -0.176; TCGA KIRP -0.199; TCGA LUAD -0.18; TCGA PAAD -0.357; TCGA PRAD -0.255; TCGA THCA -0.263; TCGA STAD -0.266 |
hsa-miR-192-5p | DEGS1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.231; TCGA COAD -0.21; TCGA ESCA -0.115; TCGA HNSC -0.08; TCGA LIHC -0.131; TCGA LUAD -0.076; TCGA PAAD -0.063; TCGA SARC -0.235; TCGA THCA -0.164; TCGA STAD -0.105 |
hsa-miR-192-5p | DNAJB4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.31; TCGA BRCA -0.181; TCGA CESC -0.181; TCGA COAD -0.309; TCGA ESCA -0.171; TCGA HNSC -0.182; TCGA LUSC -0.143; TCGA OV -0.104; TCGA PAAD -0.21; TCGA PRAD -0.341; TCGA SARC -0.218; TCGA STAD -0.259; TCGA UCEC -0.164 |
hsa-miR-192-5p | DNAJB5 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.533; TCGA BRCA -0.125; TCGA CESC -0.142; TCGA COAD -0.646; TCGA ESCA -0.271; TCGA HNSC -0.277; TCGA LIHC -0.164; TCGA LUAD -0.073; TCGA LUSC -0.152; TCGA PAAD -0.301; TCGA PRAD -0.428; TCGA SARC -0.465; TCGA STAD -0.536; TCGA UCEC -0.207 |
hsa-miR-192-5p | DST | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.296; TCGA BRCA -0.347; TCGA CESC -0.283; TCGA COAD -0.233; TCGA ESCA -0.206; TCGA HNSC -0.253; TCGA LUAD -0.058; TCGA LUSC -0.203; TCGA PRAD -0.216; TCGA SARC -0.295; TCGA THCA -0.52; TCGA STAD -0.268; TCGA UCEC -0.341 |
hsa-miR-192-5p | DSTYK | 9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.061; TCGA CESC -0.112; TCGA COAD -0.14; TCGA ESCA -0.085; TCGA LIHC -0.266; TCGA LUAD -0.074; TCGA PAAD -0.108; TCGA STAD -0.151; TCGA UCEC -0.123 |
hsa-miR-192-5p | EEA1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.081; TCGA BRCA -0.081; TCGA CESC -0.096; TCGA ESCA -0.057; TCGA HNSC -0.074; TCGA LUSC -0.071; TCGA SARC -0.102; TCGA STAD -0.099; TCGA UCEC -0.083 |
hsa-miR-192-5p | EGR1 | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.329; TCGA BRCA -0.559; TCGA CESC -0.098; TCGA ESCA -0.125; TCGA KIRP -0.102; TCGA LUAD -0.102; TCGA LUSC -0.221; TCGA PAAD -0.135; TCGA PRAD -0.402; TCGA STAD -0.188; TCGA UCEC -0.129 |
hsa-miR-192-5p | EHBP1L1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.172; TCGA BRCA -0.065; TCGA CESC -0.071; TCGA COAD -0.069; TCGA ESCA -0.073; TCGA HNSC -0.205; TCGA KIRP -0.099; TCGA LIHC -0.15; TCGA LUSC -0.124; TCGA PRAD -0.207; TCGA SARC -0.288; TCGA THCA -0.27; TCGA STAD -0.141 |
hsa-miR-192-5p | ELL2 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.256; TCGA CESC -0.172; TCGA COAD -0.171; TCGA ESCA -0.154; TCGA HNSC -0.25; TCGA LUSC -0.265; TCGA PAAD -0.154; TCGA SARC -0.311; TCGA STAD -0.196 |
hsa-miR-192-5p | EML1 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUAD; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.261; TCGA BRCA -0.067; TCGA COAD -0.502; TCGA ESCA -0.143; TCGA KIRP -0.079; TCGA LIHC -0.225; TCGA LUAD -0.059; TCGA PAAD -0.172; TCGA SARC -0.096; TCGA STAD -0.391; TCGA UCEC -0.217 |
hsa-miR-192-5p | ENDOD1 | 11 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.157; TCGA CESC -0.086; TCGA ESCA -0.064; TCGA HNSC -0.284; TCGA LIHC -0.463; TCGA LUAD -0.092; TCGA LUSC -0.213; TCGA SARC -0.341; TCGA THCA -0.344; TCGA STAD -0.101; TCGA UCEC -0.066 |
hsa-miR-192-5p | EPDR1 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.376; TCGA BRCA -0.26; TCGA ESCA -0.111; TCGA HNSC -0.242; TCGA LIHC -0.256; TCGA LUAD -0.148; TCGA PRAD -0.231; TCGA SARC -0.303; TCGA THCA -0.173; TCGA STAD -0.113; TCGA UCEC -0.177 |
hsa-miR-192-5p | EPM2A | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.257; TCGA BRCA -0.067; TCGA COAD -0.196; TCGA ESCA -0.076; TCGA HNSC -0.076; TCGA PAAD -0.08; TCGA PRAD -0.213; TCGA SARC -0.298; TCGA STAD -0.34; TCGA UCEC -0.144 |
hsa-miR-192-5p | FAM126A | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.237; TCGA BRCA -0.252; TCGA CESC -0.393; TCGA COAD -0.286; TCGA ESCA -0.219; TCGA HNSC -0.158; TCGA LUAD -0.173; TCGA LUSC -0.117; TCGA PAAD -0.258; TCGA THCA -0.148; TCGA STAD -0.105; TCGA UCEC -0.1 |
hsa-miR-192-5p | FAM189A2 | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.277; TCGA BRCA -0.502; TCGA COAD -0.598; TCGA KIRC -0.189; TCGA KIRP -0.173; TCGA LIHC -0.414; TCGA LUAD -0.231; TCGA LUSC -0.458; TCGA PRAD -0.136; TCGA SARC -0.269; TCGA STAD -0.23; TCGA UCEC -0.245 |
hsa-miR-192-5p | FBN1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.553; TCGA BRCA -0.235; TCGA CESC -0.152; TCGA COAD -0.614; TCGA ESCA -0.085; TCGA HNSC -0.246; TCGA KIRC -0.103; TCGA LIHC -0.451; TCGA LUAD -0.125; TCGA LUSC -0.274; TCGA OV -0.255; TCGA PAAD -0.33; TCGA STAD -0.18; TCGA UCEC -0.278 |
hsa-miR-192-5p | FBXO31 | 9 cancers: BLCA; BRCA; CESC; HNSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.15; TCGA BRCA -0.149; TCGA CESC -0.063; TCGA HNSC -0.06; TCGA PAAD -0.054; TCGA PRAD -0.122; TCGA THCA -0.077; TCGA STAD -0.077; TCGA UCEC -0.089 |
hsa-miR-192-5p | FGF2 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.559; TCGA BRCA -0.493; TCGA COAD -0.661; TCGA ESCA -0.1; TCGA KIRC -0.103; TCGA KIRP -0.246; TCGA OV -0.171; TCGA PAAD -0.163; TCGA PRAD -0.403; TCGA THCA -0.361; TCGA STAD -0.351; TCGA UCEC -0.369 |
hsa-miR-192-5p | FNBP1 | 9 cancers: BLCA; COAD; ESCA; LIHC; LUAD; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.207; TCGA COAD -0.346; TCGA ESCA -0.158; TCGA LIHC -0.057; TCGA LUAD -0.06; TCGA PAAD -0.261; TCGA SARC -0.255; TCGA STAD -0.366; TCGA UCEC -0.184 |
hsa-miR-192-5p | FZD1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.155; TCGA BRCA -0.056; TCGA CESC -0.076; TCGA COAD -0.292; TCGA ESCA -0.172; TCGA HNSC -0.178; TCGA LGG -0.086; TCGA LIHC -0.458; TCGA LUAD -0.135; TCGA LUSC -0.167; TCGA OV -0.243; TCGA PAAD -0.161; TCGA PRAD -0.124; TCGA STAD -0.137 |
hsa-miR-192-5p | FZD7 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.26; TCGA BRCA -0.162; TCGA CESC -0.115; TCGA COAD -0.249; TCGA ESCA -0.208; TCGA KIRC -0.095; TCGA LGG -0.213; TCGA LIHC -0.594; TCGA OV -0.134; TCGA PAAD -0.258; TCGA PRAD -0.322; TCGA STAD -0.211; TCGA UCEC -0.38 |
hsa-miR-192-5p | HBEGF | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.217; TCGA BRCA -0.186; TCGA CESC -0.214; TCGA ESCA -0.064; TCGA HNSC -0.217; TCGA KIRC -0.065; TCGA LIHC -0.234; TCGA LUAD -0.059; TCGA LUSC -0.273; TCGA PRAD -0.328; TCGA THCA -0.496; TCGA UCEC -0.106 |
hsa-miR-192-5p | HOOK3 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.057; TCGA CESC -0.051; TCGA COAD -0.144; TCGA ESCA -0.067; TCGA HNSC -0.065; TCGA KIRP -0.062; TCGA LIHC -0.09; TCGA LUSC -0.063; TCGA OV -0.092; TCGA PAAD -0.128; TCGA STAD -0.237; TCGA UCEC -0.14 |
hsa-miR-192-5p | HRH1 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.169; TCGA BRCA -0.163; TCGA COAD -0.102; TCGA HNSC -0.242; TCGA KIRP -0.188; TCGA LIHC -0.435; TCGA LUAD -0.056; TCGA LUSC -0.364; TCGA PRAD -0.186; TCGA SARC -0.174; TCGA THCA -0.507 |
hsa-miR-192-5p | HSPA2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.208; TCGA BRCA -0.104; TCGA CESC -0.254; TCGA COAD -0.341; TCGA ESCA -0.303; TCGA HNSC -0.281; TCGA KIRC -0.43; TCGA KIRP -0.12; TCGA LIHC -0.206; TCGA SARC -0.49; TCGA THCA -0.096; TCGA STAD -0.438; TCGA UCEC -0.183 |
hsa-miR-192-5p | IGDCC4 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.299; TCGA BRCA -0.195; TCGA COAD -0.22; TCGA HNSC -0.312; TCGA KIRC -0.244; TCGA KIRP -0.159; TCGA LIHC -0.739; TCGA LUSC -0.153; TCGA OV -0.208; TCGA PAAD -0.456; TCGA STAD -0.068; TCGA UCEC -0.143 |
hsa-miR-192-5p | IGF1R | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.162; TCGA CESC -0.174; TCGA COAD -0.087; TCGA ESCA -0.193; TCGA LIHC -0.58; TCGA OV -0.115; TCGA PAAD -0.231; TCGA SARC -0.234; TCGA STAD -0.147; TCGA UCEC -0.091 |
hsa-miR-192-5p | IL1R1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.186; TCGA BRCA -0.292; TCGA COAD -0.521; TCGA ESCA -0.061; TCGA HNSC -0.161; TCGA KIRC -0.054; TCGA KIRP -0.051; TCGA LUAD -0.079; TCGA LUSC -0.331; TCGA PAAD -0.311; TCGA PRAD -0.097; TCGA STAD -0.143 |
hsa-miR-192-5p | IL1RAP | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.203; TCGA CESC -0.252; TCGA COAD -0.131; TCGA ESCA -0.263; TCGA HNSC -0.135; TCGA KIRP -0.075; TCGA LUAD -0.078; TCGA LUSC -0.159; TCGA PAAD -0.158; TCGA THCA -0.567 |
hsa-miR-192-5p | INPP5F | 9 cancers: BLCA; CESC; COAD; LIHC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.102; TCGA CESC -0.124; TCGA COAD -0.08; TCGA LIHC -0.103; TCGA OV -0.089; TCGA PAAD -0.091; TCGA PRAD -0.082; TCGA STAD -0.14; TCGA UCEC -0.108 |
hsa-miR-192-5p | ITGAV | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.191; TCGA CESC -0.081; TCGA COAD -0.242; TCGA ESCA -0.082; TCGA HNSC -0.152; TCGA LIHC -0.344; TCGA LUSC -0.141; TCGA PAAD -0.155; TCGA SARC -0.282; TCGA THCA -0.116; TCGA STAD -0.087; TCGA UCEC -0.103 |
hsa-miR-192-5p | ITGB1 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.127; TCGA BRCA -0.059; TCGA COAD -0.159; TCGA HNSC -0.137; TCGA KIRP -0.076; TCGA LIHC -0.159; TCGA LUSC -0.199; TCGA OV -0.1; TCGA PAAD -0.105; TCGA PRAD -0.078; TCGA SARC -0.211; TCGA THCA -0.199; TCGA STAD -0.151; TCGA UCEC -0.107 |
hsa-miR-192-5p | KATNAL1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.374; TCGA BRCA -0.093; TCGA CESC -0.062; TCGA COAD -0.352; TCGA ESCA -0.161; TCGA LUAD -0.106; TCGA LUSC -0.113; TCGA OV -0.132; TCGA PAAD -0.226; TCGA PRAD -0.112; TCGA SARC -0.169; TCGA THCA -0.158; TCGA STAD -0.336; TCGA UCEC -0.227 |
hsa-miR-192-5p | KCTD12 | 14 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.423; TCGA BRCA -0.322; TCGA COAD -0.452; TCGA KIRC -0.121; TCGA KIRP -0.068; TCGA LGG -0.112; TCGA LIHC -0.406; TCGA LUAD -0.096; TCGA LUSC -0.283; TCGA OV -0.138; TCGA PAAD -0.123; TCGA THCA -0.416; TCGA STAD -0.146; TCGA UCEC -0.245 |
hsa-miR-192-5p | KCTD15 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.282; TCGA CESC -0.281; TCGA COAD -0.336; TCGA ESCA -0.333; TCGA HNSC -0.147; TCGA LGG -0.084; TCGA LIHC -0.407; TCGA PAAD -0.131; TCGA STAD -0.31; TCGA UCEC -0.22 |
hsa-miR-192-5p | KIDINS220 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; OV; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.053; TCGA COAD -0.068; TCGA ESCA -0.065; TCGA HNSC -0.103; TCGA LUAD -0.061; TCGA OV -0.071; TCGA THCA -0.078; TCGA STAD -0.102; TCGA UCEC -0.136 |
hsa-miR-192-5p | KLF10 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.195; TCGA BRCA -0.154; TCGA CESC -0.077; TCGA COAD -0.067; TCGA ESCA -0.056; TCGA HNSC -0.273; TCGA LUSC -0.315; TCGA PAAD -0.102; TCGA PRAD -0.206; TCGA STAD -0.191; TCGA UCEC -0.111 |
hsa-miR-192-5p | LHFP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.395; TCGA BRCA -0.453; TCGA CESC -0.09; TCGA COAD -0.503; TCGA ESCA -0.079; TCGA HNSC -0.09; TCGA LIHC -0.409; TCGA LUAD -0.095; TCGA LUSC -0.245; TCGA OV -0.21; TCGA PAAD -0.266; TCGA PRAD -0.085; TCGA THCA -0.189; TCGA STAD -0.252; TCGA UCEC -0.253 |
hsa-miR-192-5p | LOXL2 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.18; TCGA BRCA -0.067; TCGA COAD -0.258; TCGA KIRC -0.121; TCGA KIRP -0.133; TCGA LIHC -0.406; TCGA LUAD -0.073; TCGA LUSC -0.333; TCGA OV -0.131; TCGA PAAD -0.202; TCGA THCA -0.478 |
hsa-miR-192-5p | LRRC8C | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.162; TCGA BRCA -0.116; TCGA CESC -0.187; TCGA COAD -0.35; TCGA ESCA -0.125; TCGA LIHC -0.274; TCGA LUAD -0.101; TCGA LUSC -0.202; TCGA OV -0.078; TCGA PAAD -0.256; TCGA THCA -0.171; TCGA STAD -0.09; TCGA UCEC -0.139 |
hsa-miR-192-5p | MACF1 | 12 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.157; TCGA COAD -0.178; TCGA ESCA -0.109; TCGA HNSC -0.201; TCGA LIHC -0.069; TCGA LUAD -0.064; TCGA LUSC -0.22; TCGA PAAD -0.112; TCGA SARC -0.304; TCGA THCA -0.109; TCGA STAD -0.203; TCGA UCEC -0.13 |
hsa-miR-192-5p | MAP1LC3B | 10 cancers: BLCA; CESC; HNSC; LIHC; LUSC; OV; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.096; TCGA CESC -0.063; TCGA HNSC -0.12; TCGA LIHC -0.135; TCGA LUSC -0.097; TCGA OV -0.053; TCGA PRAD -0.119; TCGA THCA -0.082; TCGA STAD -0.08; TCGA UCEC -0.075 |
hsa-miR-192-5p | MCAM | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.244; TCGA BRCA -0.3; TCGA CESC -0.214; TCGA COAD -0.312; TCGA HNSC -0.159; TCGA LIHC -0.407; TCGA LUAD -0.105; TCGA LUSC -0.321; TCGA PAAD -0.241; TCGA PRAD -0.29; TCGA SARC -0.421; TCGA THCA -0.305; TCGA STAD -0.296; TCGA UCEC -0.197 |
hsa-miR-192-5p | MEIS2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.318; TCGA BRCA -0.35; TCGA COAD -0.801; TCGA HNSC -0.085; TCGA LIHC -0.251; TCGA LUSC -0.138; TCGA PRAD -0.493; TCGA SARC -0.422; TCGA STAD -0.179; TCGA UCEC -0.179 |
hsa-miR-192-5p | MSN | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.343; TCGA CESC -0.339; TCGA COAD -0.437; TCGA ESCA -0.271; TCGA HNSC -0.131; TCGA LIHC -0.293; TCGA LUAD -0.13; TCGA LUSC -0.235; TCGA PAAD -0.258; TCGA PRAD -0.152; TCGA SARC -0.157; TCGA THCA -0.29; TCGA STAD -0.185; TCGA UCEC -0.061 |
hsa-miR-192-5p | MSRB3 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.721; TCGA BRCA -0.471; TCGA CESC -0.176; TCGA COAD -0.745; TCGA ESCA -0.171; TCGA HNSC -0.15; TCGA KIRP -0.1; TCGA LIHC -0.423; TCGA LUAD -0.123; TCGA LUSC -0.349; TCGA OV -0.205; TCGA PAAD -0.267; TCGA PRAD -0.448; TCGA SARC -0.432; TCGA THCA -0.299; TCGA STAD -0.54; TCGA UCEC -0.439 |
hsa-miR-192-5p | MT1X | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.326; TCGA BRCA -0.297; TCGA CESC -0.307; TCGA COAD -0.233; TCGA ESCA -0.242; TCGA HNSC -0.266; TCGA LUAD -0.103; TCGA LUSC -0.199; TCGA PAAD -0.27; TCGA PRAD -0.268; TCGA STAD -0.174 |
hsa-miR-192-5p | NFIB | 9 cancers: BLCA; BRCA; COAD; LGG; LUAD; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.088; TCGA BRCA -0.206; TCGA COAD -0.095; TCGA LGG -0.086; TCGA LUAD -0.087; TCGA PAAD -0.091; TCGA PRAD -0.086; TCGA THCA -0.146; TCGA STAD -0.082 |
hsa-miR-192-5p | NIN | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.066; TCGA CESC -0.167; TCGA COAD -0.174; TCGA ESCA -0.171; TCGA LIHC -0.161; TCGA LUAD -0.058; TCGA PAAD -0.297; TCGA THCA -0.17; TCGA STAD -0.24; TCGA UCEC -0.054 |
hsa-miR-192-5p | NOD2 | 10 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.163; TCGA CESC -0.228; TCGA ESCA -0.316; TCGA HNSC -0.391; TCGA LGG -0.24; TCGA LUSC -0.213; TCGA PAAD -0.35; TCGA PRAD -0.138; TCGA THCA -0.606; TCGA STAD -0.093 |
hsa-miR-192-5p | OGFRL1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.149; TCGA CESC -0.166; TCGA COAD -0.19; TCGA ESCA -0.212; TCGA KIRP -0.068; TCGA LIHC -0.282; TCGA LUAD -0.106; TCGA PAAD -0.211; TCGA SARC -0.128; TCGA THCA -0.358; TCGA STAD -0.198 |
hsa-miR-192-5p | OSBPL6 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.488; TCGA CESC -0.472; TCGA COAD -0.491; TCGA ESCA -0.522; TCGA HNSC -0.118; TCGA OV -0.261; TCGA PAAD -0.15; TCGA SARC -0.227; TCGA STAD -0.371; TCGA UCEC -0.158 |
hsa-miR-192-5p | OSBPL8 | 11 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.072; TCGA CESC -0.072; TCGA COAD -0.131; TCGA ESCA -0.061; TCGA LIHC -0.073; TCGA LUSC -0.058; TCGA OV -0.085; TCGA PAAD -0.133; TCGA THCA -0.092; TCGA STAD -0.097; TCGA UCEC -0.118 |
hsa-miR-192-5p | PAFAH1B1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.071; TCGA COAD -0.097; TCGA ESCA -0.05; TCGA HNSC -0.073; TCGA LIHC -0.099; TCGA LUSC -0.093; TCGA PAAD -0.058; TCGA PRAD -0.083; TCGA STAD -0.081; TCGA UCEC -0.05 |
hsa-miR-192-5p | PANX1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.107; TCGA CESC -0.098; TCGA COAD -0.075; TCGA ESCA -0.064; TCGA HNSC -0.165; TCGA KIRC -0.059; TCGA PAAD -0.117; TCGA SARC -0.173; TCGA THCA -0.169 |
hsa-miR-192-5p | PCDH7 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.748; TCGA BRCA -0.224; TCGA COAD -0.679; TCGA ESCA -0.134; TCGA HNSC -0.339; TCGA KIRC -0.279; TCGA LIHC -0.546; TCGA LUSC -0.331; TCGA OV -0.194; TCGA PAAD -0.246; TCGA PRAD -0.483; TCGA SARC -0.582; TCGA THCA -0.314; TCGA STAD -0.383; TCGA UCEC -0.155 |
hsa-miR-192-5p | PCOLCE2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.606; TCGA BRCA -0.667; TCGA CESC -0.21; TCGA COAD -0.774; TCGA ESCA -0.234; TCGA LUAD -0.133; TCGA PAAD -0.242; TCGA PRAD -0.366; TCGA STAD -0.521; TCGA UCEC -0.183 |
hsa-miR-192-5p | PDE2A | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.382; TCGA BRCA -0.619; TCGA CESC -0.21; TCGA COAD -0.658; TCGA HNSC -0.219; TCGA LUAD -0.156; TCGA LUSC -0.338; TCGA PAAD -0.295; TCGA PRAD -0.348; TCGA SARC -0.188; TCGA STAD -0.343; TCGA UCEC -0.454 |
hsa-miR-192-5p | PDLIM3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.825; TCGA BRCA -0.364; TCGA CESC -0.227; TCGA COAD -0.69; TCGA ESCA -0.204; TCGA HNSC -0.298; TCGA LIHC -0.497; TCGA LUAD -0.078; TCGA LUSC -0.327; TCGA OV -0.281; TCGA PAAD -0.37; TCGA PRAD -0.373; TCGA SARC -1.04; TCGA STAD -0.528; TCGA UCEC -0.543 |
hsa-miR-192-5p | PHF19 | 9 cancers: BLCA; KIRC; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.099; TCGA KIRC -0.06; TCGA LIHC -0.222; TCGA PAAD -0.09; TCGA PRAD -0.068; TCGA SARC -0.093; TCGA THCA -0.159; TCGA STAD -0.1; TCGA UCEC -0.063 |
hsa-miR-192-5p | PLAU | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.241; TCGA CESC -0.356; TCGA COAD -0.274; TCGA ESCA -0.223; TCGA HNSC -0.265; TCGA KIRC -0.194; TCGA LGG -0.184; TCGA LIHC -0.537; TCGA LUAD -0.14; TCGA LUSC -0.231; TCGA PAAD -0.475; TCGA PRAD -0.105; TCGA THCA -1.102 |
hsa-miR-192-5p | PLEKHG2 | 9 cancers: BLCA; COAD; KIRP; LGG; LIHC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.07; TCGA COAD -0.25; TCGA KIRP -0.061; TCGA LGG -0.145; TCGA LIHC -0.287; TCGA PAAD -0.25; TCGA THCA -0.286; TCGA STAD -0.106; TCGA UCEC -0.13 |
hsa-miR-192-5p | PLS3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.187; TCGA BRCA -0.178; TCGA CESC -0.163; TCGA COAD -0.092; TCGA ESCA -0.191; TCGA HNSC -0.217; TCGA KIRC -0.146; TCGA LUAD -0.161; TCGA LUSC -0.077; TCGA PAAD -0.113; TCGA PRAD -0.153; TCGA SARC -0.259; TCGA THCA -0.077; TCGA STAD -0.115 |
hsa-miR-192-5p | PPP1CB | 9 cancers: BLCA; ESCA; HNSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.086; TCGA ESCA -0.095; TCGA HNSC -0.099; TCGA OV -0.065; TCGA PRAD -0.064; TCGA SARC -0.189; TCGA THCA -0.101; TCGA STAD -0.164; TCGA UCEC -0.083 |
hsa-miR-192-5p | PPP1R12A | 9 cancers: BLCA; CESC; COAD; ESCA; LIHC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.19; TCGA CESC -0.06; TCGA COAD -0.13; TCGA ESCA -0.063; TCGA LIHC -0.109; TCGA PRAD -0.097; TCGA SARC -0.255; TCGA STAD -0.23; TCGA UCEC -0.113 |
hsa-miR-192-5p | PRICKLE1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.456; TCGA BRCA -0.071; TCGA CESC -0.257; TCGA COAD -0.647; TCGA ESCA -0.31; TCGA HNSC -0.275; TCGA KIRC -0.07; TCGA KIRP -0.098; TCGA LIHC -0.648; TCGA LUAD -0.134; TCGA LUSC -0.329; TCGA OV -0.299; TCGA PAAD -0.424; TCGA PRAD -0.205; TCGA THCA -0.285; TCGA STAD -0.288; TCGA UCEC -0.296 |
hsa-miR-192-5p | PRNP | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.406; TCGA BRCA -0.157; TCGA CESC -0.307; TCGA COAD -0.307; TCGA ESCA -0.287; TCGA HNSC -0.195; TCGA LIHC -0.342; TCGA LUAD -0.085; TCGA LUSC -0.131; TCGA PAAD -0.204; TCGA PRAD -0.208; TCGA SARC -0.11; TCGA STAD -0.33; TCGA UCEC -0.246 |
hsa-miR-192-5p | PRSS23 | 12 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.306; TCGA BRCA -0.12; TCGA HNSC -0.211; TCGA LIHC -0.406; TCGA LUAD -0.088; TCGA LUSC -0.29; TCGA PAAD -0.242; TCGA PRAD -0.137; TCGA SARC -0.353; TCGA THCA -0.674; TCGA STAD -0.211; TCGA UCEC -0.211 |
hsa-miR-192-5p | PTBP2 | 9 cancers: BLCA; COAD; LGG; LIHC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.114; TCGA COAD -0.122; TCGA LGG -0.069; TCGA LIHC -0.118; TCGA PAAD -0.073; TCGA PRAD -0.106; TCGA SARC -0.254; TCGA STAD -0.24; TCGA UCEC -0.105 |
hsa-miR-192-5p | PTP4A3 | 9 cancers: BLCA; LGG; LIHC; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.122; TCGA LGG -0.166; TCGA LIHC -0.394; TCGA LUSC -0.097; TCGA OV -0.134; TCGA PAAD -0.208; TCGA THCA -0.393; TCGA STAD -0.14; TCGA UCEC -0.115 |
hsa-miR-192-5p | PTPRE | 10 cancers: BLCA; BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.099; TCGA BRCA -0.114; TCGA HNSC -0.132; TCGA KIRP -0.063; TCGA LIHC -0.465; TCGA LUAD -0.143; TCGA LUSC -0.294; TCGA PAAD -0.097; TCGA PRAD -0.088; TCGA THCA -0.537 |
hsa-miR-192-5p | PXDN | 12 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.378; TCGA COAD -0.404; TCGA ESCA -0.065; TCGA HNSC -0.165; TCGA LIHC -0.353; TCGA LUAD -0.129; TCGA LUSC -0.248; TCGA OV -0.152; TCGA PAAD -0.292; TCGA PRAD -0.121; TCGA THCA -0.565; TCGA UCEC -0.212 |
hsa-miR-192-5p | RAB23 | 13 cancers: BLCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.403; TCGA COAD -0.3; TCGA ESCA -0.091; TCGA KIRC -0.052; TCGA LIHC -0.159; TCGA LUAD -0.075; TCGA LUSC -0.087; TCGA OV -0.1; TCGA PAAD -0.228; TCGA PRAD -0.109; TCGA SARC -0.429; TCGA STAD -0.342; TCGA UCEC -0.224 |
hsa-miR-192-5p | RADIL | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.189; TCGA BRCA -0.241; TCGA CESC -0.117; TCGA COAD -0.649; TCGA ESCA -0.348; TCGA KIRC -0.119; TCGA KIRP -0.288; TCGA LGG -0.112; TCGA LIHC -0.372; TCGA LUAD -0.153; TCGA PAAD -0.158; TCGA STAD -0.427; TCGA UCEC -0.344 |
hsa-miR-192-5p | RASSF8 | 12 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.26; TCGA BRCA -0.151; TCGA COAD -0.493; TCGA ESCA -0.177; TCGA LIHC -0.295; TCGA LUAD -0.136; TCGA LUSC -0.19; TCGA OV -0.197; TCGA PAAD -0.28; TCGA THCA -0.142; TCGA STAD -0.377; TCGA UCEC -0.307 |
hsa-miR-192-5p | RBP7 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.203; TCGA BRCA -0.369; TCGA CESC -0.369; TCGA COAD -0.432; TCGA ESCA -0.167; TCGA LUAD -0.084; TCGA PAAD -0.28; TCGA PRAD -0.228; TCGA STAD -0.301; TCGA UCEC -0.348 |
hsa-miR-192-5p | RCBTB2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.239; TCGA BRCA -0.208; TCGA CESC -0.071; TCGA COAD -0.156; TCGA ESCA -0.124; TCGA HNSC -0.086; TCGA KIRP -0.064; TCGA LGG -0.08; TCGA LIHC -0.078; TCGA LUSC -0.167; TCGA OV -0.142; TCGA PAAD -0.079; TCGA PRAD -0.251; TCGA STAD -0.203; TCGA UCEC -0.145 |
hsa-miR-192-5p | SEPT10 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.109; TCGA BRCA -0.085; TCGA CESC -0.136; TCGA ESCA -0.104; TCGA HNSC -0.094; TCGA OV -0.091; TCGA PRAD -0.097; TCGA SARC -0.153; TCGA STAD -0.144; TCGA UCEC -0.104 |
hsa-miR-192-5p | SERTAD4 | 9 cancers: BLCA; COAD; ESCA; KIRC; LUAD; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.204; TCGA COAD -0.464; TCGA ESCA -0.195; TCGA KIRC -0.085; TCGA LUAD -0.159; TCGA OV -0.153; TCGA PRAD -0.225; TCGA STAD -0.389; TCGA UCEC -0.348 |
hsa-miR-192-5p | SGCB | 11 cancers: BLCA; BRCA; COAD; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.293; TCGA BRCA -0.082; TCGA COAD -0.178; TCGA LIHC -0.155; TCGA LUSC -0.123; TCGA OV -0.105; TCGA PRAD -0.185; TCGA SARC -0.212; TCGA THCA -0.142; TCGA STAD -0.146; TCGA UCEC -0.082 |
hsa-miR-192-5p | SLC16A7 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.315; TCGA BRCA -0.362; TCGA COAD -0.737; TCGA ESCA -0.078; TCGA KIRC -0.216; TCGA LIHC -0.255; TCGA LUAD -0.071; TCGA PRAD -0.194; TCGA SARC -0.304; TCGA STAD -0.297; TCGA UCEC -0.137 |
hsa-miR-192-5p | SLC25A30 | 9 cancers: BLCA; BRCA; COAD; HNSC; LUSC; OV; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.133; TCGA BRCA -0.059; TCGA COAD -0.078; TCGA HNSC -0.069; TCGA LUSC -0.096; TCGA OV -0.06; TCGA PAAD -0.103; TCGA THCA -0.098; TCGA STAD -0.08 |
hsa-miR-192-5p | SLCO3A1 | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.153; TCGA BRCA -0.133; TCGA CESC -0.094; TCGA ESCA -0.148; TCGA KIRC -0.099; TCGA LIHC -0.393; TCGA LUAD -0.113; TCGA PAAD -0.209; TCGA PRAD -0.275; TCGA THCA -0.122; TCGA STAD -0.138 |
hsa-miR-192-5p | SPARC | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.343; TCGA BRCA -0.203; TCGA CESC -0.101; TCGA COAD -0.489; TCGA ESCA -0.081; TCGA HNSC -0.253; TCGA LIHC -0.376; TCGA LUAD -0.086; TCGA LUSC -0.336; TCGA OV -0.221; TCGA PAAD -0.311; TCGA THCA -0.325; TCGA UCEC -0.186 |
hsa-miR-192-5p | ST3GAL6 | 9 cancers: BLCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.281; TCGA COAD -0.458; TCGA HNSC -0.114; TCGA KIRC -0.079; TCGA LUAD -0.082; TCGA LUSC -0.254; TCGA PAAD -0.233; TCGA PRAD -0.18; TCGA STAD -0.136 |
hsa-miR-192-5p | STK17B | 9 cancers: BLCA; COAD; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.116; TCGA COAD -0.096; TCGA LIHC -0.327; TCGA LUAD -0.087; TCGA LUSC -0.152; TCGA OV -0.079; TCGA PAAD -0.192; TCGA PRAD -0.162; TCGA THCA -0.347 |
hsa-miR-192-5p | THBD | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.367; TCGA BRCA -0.324; TCGA CESC -0.515; TCGA COAD -0.34; TCGA ESCA -0.285; TCGA KIRP -0.102; TCGA LIHC -0.24; TCGA LUAD -0.092; TCGA LUSC -0.369; TCGA PAAD -0.272; TCGA PRAD -0.22; TCGA THCA -0.274; TCGA STAD -0.192; TCGA UCEC -0.221 |
hsa-miR-192-5p | TMEM136 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.087; TCGA BRCA -0.051; TCGA COAD -0.283; TCGA KIRC -0.124; TCGA KIRP -0.099; TCGA LIHC -0.398; TCGA PAAD -0.074; TCGA SARC -0.126; TCGA STAD -0.21; TCGA UCEC -0.148 |
hsa-miR-192-5p | TMEM200A | 9 cancers: BLCA; BRCA; LIHC; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.397; TCGA BRCA -0.089; TCGA LIHC -0.63; TCGA LUSC -0.189; TCGA OV -0.274; TCGA PAAD -0.184; TCGA SARC -0.536; TCGA THCA -0.982; TCGA UCEC -0.175 |
hsa-miR-192-5p | TMEM30A | 9 cancers: BLCA; COAD; KIRC; LUSC; OV; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.051; TCGA COAD -0.085; TCGA KIRC -0.077; TCGA LUSC -0.092; TCGA OV -0.076; TCGA PRAD -0.091; TCGA SARC -0.116; TCGA THCA -0.055; TCGA STAD -0.059 |
hsa-miR-192-5p | TPM4 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.142; TCGA CESC -0.078; TCGA COAD -0.111; TCGA ESCA -0.051; TCGA HNSC -0.133; TCGA KIRC -0.175; TCGA LIHC -0.441; TCGA LUSC -0.172; TCGA SARC -0.175; TCGA THCA -0.342; TCGA UCEC -0.095 |
hsa-miR-192-5p | TRIM23 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.122; TCGA BRCA -0.096; TCGA CESC -0.052; TCGA COAD -0.134; TCGA ESCA -0.066; TCGA LUAD -0.081; TCGA PAAD -0.101; TCGA PRAD -0.075; TCGA STAD -0.172; TCGA UCEC -0.116 |
hsa-miR-192-5p | TRPC1 | 15 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.208; TCGA BRCA -0.28; TCGA COAD -0.518; TCGA ESCA -0.134; TCGA KIRC -0.08; TCGA KIRP -0.105; TCGA LIHC -0.348; TCGA LUAD -0.102; TCGA LUSC -0.149; TCGA OV -0.135; TCGA PAAD -0.261; TCGA PRAD -0.238; TCGA SARC -0.167; TCGA STAD -0.39; TCGA UCEC -0.382 |
hsa-miR-192-5p | WDR47 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.118; TCGA CESC -0.151; TCGA COAD -0.112; TCGA ESCA -0.169; TCGA HNSC -0.104; TCGA LIHC -0.133; TCGA LUAD -0.055; TCGA PAAD -0.061; TCGA SARC -0.125; TCGA STAD -0.165; TCGA UCEC -0.055 |
hsa-miR-192-5p | WNK1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; THCA; STAD | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.071; TCGA CESC -0.131; TCGA COAD -0.072; TCGA ESCA -0.094; TCGA HNSC -0.158; TCGA LUAD -0.078; TCGA LUSC -0.077; TCGA THCA -0.169; TCGA STAD -0.142 |
hsa-miR-192-5p | WWC2 | 9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.209; TCGA BRCA -0.15; TCGA COAD -0.374; TCGA HNSC -0.09; TCGA LUAD -0.057; TCGA LUSC -0.187; TCGA PAAD -0.144; TCGA STAD -0.147; TCGA UCEC -0.116 |
hsa-miR-192-5p | WWC3 | 11 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.144; TCGA CESC -0.133; TCGA COAD -0.11; TCGA ESCA -0.157; TCGA LIHC -0.254; TCGA LUAD -0.114; TCGA LUSC -0.14; TCGA PAAD -0.16; TCGA THCA -0.162; TCGA STAD -0.242; TCGA UCEC -0.117 |
hsa-miR-192-5p | ZNF385B | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.521; TCGA BRCA -0.228; TCGA CESC -0.242; TCGA COAD -0.874; TCGA ESCA -0.149; TCGA HNSC -0.284; TCGA LUAD -0.249; TCGA LUSC -0.544; TCGA PAAD -0.181; TCGA STAD -0.378 |
hsa-miR-192-5p | KCNQ5 | 11 cancers: BLCA; CESC; COAD; ESCA; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.775; TCGA CESC -0.354; TCGA COAD -0.744; TCGA ESCA -0.664; TCGA LUAD -0.328; TCGA OV -0.457; TCGA PAAD -0.38; TCGA PRAD -0.302; TCGA THCA -0.314; TCGA STAD -0.516; TCGA UCEC -0.151 |
hsa-miR-192-5p | IFI44L | 9 cancers: BLCA; COAD; ESCA; KIRP; LGG; LIHC; LUSC; PAAD; SARC | MirTarget | TCGA BLCA -0.163; TCGA COAD -0.53; TCGA ESCA -0.09; TCGA KIRP -0.09; TCGA LGG -0.178; TCGA LIHC -0.226; TCGA LUSC -0.191; TCGA PAAD -0.196; TCGA SARC -0.418 |
hsa-miR-192-5p | RNF217 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.417; TCGA BRCA -0.114; TCGA CESC -0.269; TCGA COAD -0.199; TCGA ESCA -0.49; TCGA HNSC -0.214; TCGA KIRC -0.053; TCGA PAAD -0.264; TCGA SARC -0.188; TCGA STAD -0.358 |
hsa-miR-192-5p | SOD2 | 9 cancers: BLCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.268; TCGA CESC -0.085; TCGA COAD -0.159; TCGA ESCA -0.052; TCGA LUSC -0.211; TCGA PAAD -0.194; TCGA PRAD -0.26; TCGA SARC -0.243; TCGA THCA -0.113 |
hsa-miR-192-5p | CD93 | 11 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.224; TCGA BRCA -0.259; TCGA COAD -0.38; TCGA LIHC -0.233; TCGA LUAD -0.092; TCGA LUSC -0.394; TCGA PAAD -0.271; TCGA PRAD -0.104; TCGA THCA -0.343; TCGA STAD -0.055; TCGA UCEC -0.188 |
hsa-miR-192-5p | RBMS3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.601; TCGA BRCA -0.506; TCGA CESC -0.211; TCGA COAD -0.515; TCGA ESCA -0.151; TCGA LIHC -0.283; TCGA LUAD -0.206; TCGA LUSC -0.388; TCGA OV -0.317; TCGA PAAD -0.361; TCGA PRAD -0.312; TCGA STAD -0.344; TCGA UCEC -0.199 |
hsa-miR-192-5p | ZC3H6 | 9 cancers: BLCA; BRCA; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.09; TCGA BRCA -0.096; TCGA KIRP -0.072; TCGA LUAD -0.068; TCGA LUSC -0.116; TCGA PAAD -0.064; TCGA SARC -0.074; TCGA STAD -0.184; TCGA UCEC -0.127 |
hsa-miR-192-5p | SAMD4A | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.423; TCGA BRCA -0.286; TCGA COAD -0.361; TCGA HNSC -0.167; TCGA KIRC -0.066; TCGA LUAD -0.175; TCGA LUSC -0.456; TCGA PAAD -0.243; TCGA PRAD -0.183; TCGA SARC -0.158; TCGA THCA -0.462; TCGA STAD -0.282; TCGA UCEC -0.209 |
hsa-miR-192-5p | ATP8B4 | 12 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.405; TCGA BRCA -0.251; TCGA CESC -0.139; TCGA COAD -0.282; TCGA LIHC -0.112; TCGA LUAD -0.075; TCGA LUSC -0.221; TCGA PAAD -0.295; TCGA SARC -0.611; TCGA THCA -0.237; TCGA STAD -0.096; TCGA UCEC -0.143 |
hsa-miR-192-5p | SH3RF3 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.36; TCGA BRCA -0.233; TCGA COAD -0.288; TCGA ESCA -0.078; TCGA HNSC -0.168; TCGA LIHC -0.576; TCGA LUSC -0.102; TCGA OV -0.125; TCGA PAAD -0.176; TCGA PRAD -0.153; TCGA THCA -0.288; TCGA STAD -0.197; TCGA UCEC -0.203 |
hsa-miR-192-5p | SCN3A | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA BRCA -0.711; TCGA COAD -0.384; TCGA KIRC -0.329; TCGA KIRP -0.318; TCGA OV -0.235; TCGA PAAD -0.221; TCGA PRAD -0.141; TCGA SARC -0.721; TCGA STAD -0.179; TCGA UCEC -0.247 |
hsa-miR-192-5p | FLI1 | 11 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.245; TCGA BRCA -0.234; TCGA CESC -0.132; TCGA COAD -0.404; TCGA LIHC -0.231; TCGA LUAD -0.083; TCGA LUSC -0.248; TCGA PAAD -0.369; TCGA THCA -0.178; TCGA STAD -0.087; TCGA UCEC -0.151 |
hsa-miR-192-5p | LEFTY2 | 11 cancers: BLCA; BRCA; COAD; KIRC; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.869; TCGA BRCA -0.638; TCGA COAD -1.005; TCGA KIRC -0.188; TCGA LGG -0.456; TCGA LUAD -0.205; TCGA LUSC -0.492; TCGA PAAD -0.355; TCGA SARC -0.569; TCGA STAD -0.229; TCGA UCEC -0.334 |
hsa-miR-192-5p | BHLHE22 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.28; TCGA BRCA -0.328; TCGA CESC -0.14; TCGA COAD -0.511; TCGA ESCA -0.162; TCGA LIHC -0.517; TCGA LUAD -0.063; TCGA LUSC -0.314; TCGA OV -0.259; TCGA PAAD -0.433; TCGA SARC -0.635; TCGA THCA -0.273; TCGA STAD -0.246 |
hsa-miR-192-5p | ZEB2 | 13 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.438; TCGA BRCA -0.238; TCGA CESC -0.118; TCGA COAD -0.478; TCGA LIHC -0.325; TCGA LUAD -0.086; TCGA LUSC -0.351; TCGA OV -0.094; TCGA PAAD -0.314; TCGA SARC -0.225; TCGA THCA -0.225; TCGA STAD -0.188; TCGA UCEC -0.194 |
hsa-miR-192-5p | LSAMP | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.359; TCGA BRCA -0.226; TCGA COAD -0.549; TCGA KIRC -0.468; TCGA KIRP -0.146; TCGA LIHC -0.723; TCGA OV -0.211; TCGA PAAD -0.2; TCGA PRAD -0.322; TCGA THCA -0.275; TCGA STAD -0.238; TCGA UCEC -0.268 |
hsa-miR-192-5p | PCDH9 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.579; TCGA BRCA -0.421; TCGA COAD -0.764; TCGA ESCA -0.339; TCGA KIRC -0.197; TCGA LUAD -0.15; TCGA LUSC -0.322; TCGA OV -0.448; TCGA PAAD -0.368; TCGA PRAD -0.228; TCGA STAD -0.612; TCGA UCEC -0.285 |
hsa-miR-192-5p | POU2F2 | 9 cancers: BLCA; CESC; COAD; KIRP; LIHC; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.287; TCGA CESC -0.104; TCGA COAD -0.389; TCGA KIRP -0.066; TCGA LIHC -0.341; TCGA LUSC -0.261; TCGA PAAD -0.373; TCGA PRAD -0.104; TCGA STAD -0.15 |
hsa-miR-192-5p | VASH1 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | mirMAP | TCGA BLCA -0.092; TCGA BRCA -0.114; TCGA CESC -0.061; TCGA COAD -0.301; TCGA KIRP -0.07; TCGA LIHC -0.343; TCGA LUAD -0.062; TCGA LUSC -0.214; TCGA PAAD -0.232; TCGA THCA -0.327; TCGA UCEC -0.134 |
hsa-miR-192-5p | CYBRD1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.476; TCGA BRCA -0.395; TCGA COAD -0.579; TCGA ESCA -0.09; TCGA HNSC -0.177; TCGA KIRC -0.149; TCGA LIHC -0.301; TCGA LUAD -0.16; TCGA LUSC -0.25; TCGA OV -0.193; TCGA PAAD -0.252; TCGA PRAD -0.279; TCGA STAD -0.23; TCGA UCEC -0.311 |
hsa-miR-192-5p | ADCY2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.575; TCGA BRCA -0.187; TCGA COAD -0.692; TCGA ESCA -0.268; TCGA HNSC -0.429; TCGA KIRP -0.195; TCGA OV -0.418; TCGA PRAD -0.23; TCGA SARC -0.443; TCGA THCA -0.307; TCGA STAD -0.49; TCGA UCEC -0.309 |
hsa-miR-192-5p | PGR | 14 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.48; TCGA BRCA -0.652; TCGA COAD -0.756; TCGA ESCA -0.103; TCGA KIRC -0.098; TCGA LIHC -0.424; TCGA LUAD -0.156; TCGA LUSC -0.456; TCGA PAAD -0.216; TCGA PRAD -0.465; TCGA SARC -0.668; TCGA THCA -0.755; TCGA STAD -0.459; TCGA UCEC -0.323 |
hsa-miR-192-5p | SH3PXD2A | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.296; TCGA BRCA -0.06; TCGA CESC -0.111; TCGA COAD -0.15; TCGA ESCA -0.109; TCGA HNSC -0.188; TCGA KIRP -0.091; TCGA LUSC -0.101; TCGA PAAD -0.179; TCGA PRAD -0.169; TCGA THCA -0.233; TCGA STAD -0.177; TCGA UCEC -0.157 |
hsa-miR-192-5p | BVES | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.441; TCGA BRCA -0.193; TCGA COAD -0.678; TCGA ESCA -0.238; TCGA KIRC -0.223; TCGA KIRP -0.1; TCGA LIHC -0.288; TCGA OV -0.256; TCGA PAAD -0.206; TCGA PRAD -0.324; TCGA SARC -0.349; TCGA STAD -0.52; TCGA UCEC -0.27 |
hsa-miR-192-5p | C1orf21 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LUSC; OV; SARC; THCA; STAD | mirMAP; miRNATAP | TCGA BLCA -0.2; TCGA BRCA -0.161; TCGA HNSC -0.179; TCGA KIRC -0.156; TCGA LUSC -0.123; TCGA OV -0.174; TCGA SARC -0.16; TCGA THCA -0.266; TCGA STAD -0.128 |
hsa-miR-192-5p | PDLIM2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.258; TCGA BRCA -0.127; TCGA CESC -0.175; TCGA COAD -0.188; TCGA ESCA -0.082; TCGA HNSC -0.255; TCGA LGG -0.057; TCGA LUAD -0.101; TCGA LUSC -0.338; TCGA OV -0.074; TCGA PAAD -0.121; TCGA PRAD -0.079; TCGA THCA -0.27; TCGA STAD -0.094; TCGA UCEC -0.13 |
hsa-miR-192-5p | MTSS1L | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.082; TCGA CESC -0.182; TCGA COAD -0.195; TCGA ESCA -0.19; TCGA HNSC -0.109; TCGA LUAD -0.099; TCGA LUSC -0.125; TCGA PAAD -0.156; TCGA SARC -0.268; TCGA THCA -0.242; TCGA STAD -0.295; TCGA UCEC -0.143 |
hsa-miR-192-5p | PHF21A | 9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LIHC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.075; TCGA CESC -0.065; TCGA COAD -0.162; TCGA ESCA -0.096; TCGA KIRP -0.057; TCGA LIHC -0.187; TCGA PAAD -0.102; TCGA STAD -0.188; TCGA UCEC -0.072 |
hsa-miR-192-5p | SCRN1 | 12 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.117; TCGA COAD -0.18; TCGA KIRC -0.223; TCGA KIRP -0.136; TCGA LIHC -0.65; TCGA LUAD -0.08; TCGA OV -0.087; TCGA PAAD -0.147; TCGA PRAD -0.184; TCGA THCA -0.19; TCGA STAD -0.218; TCGA UCEC -0.099 |
hsa-miR-192-5p | JDP2 | 10 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.111; TCGA BRCA -0.228; TCGA HNSC -0.082; TCGA LIHC -0.117; TCGA LUAD -0.095; TCGA LUSC -0.098; TCGA PAAD -0.076; TCGA PRAD -0.156; TCGA THCA -0.213; TCGA STAD -0.083 |
hsa-miR-192-5p | NTRK3 | 12 cancers: BLCA; BRCA; COAD; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.517; TCGA BRCA -0.452; TCGA COAD -0.899; TCGA KIRP -0.13; TCGA LUAD -0.081; TCGA LUSC -0.386; TCGA OV -0.28; TCGA PAAD -0.276; TCGA PRAD -0.447; TCGA THCA -0.293; TCGA STAD -0.471; TCGA UCEC -0.46 |
hsa-miR-192-5p | ARID5B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.217; TCGA BRCA -0.191; TCGA CESC -0.102; TCGA COAD -0.076; TCGA ESCA -0.055; TCGA LIHC -0.161; TCGA LUAD -0.057; TCGA OV -0.108; TCGA PAAD -0.23; TCGA SARC -0.19; TCGA THCA -0.408; TCGA STAD -0.078; TCGA UCEC -0.188 |
hsa-miR-192-5p | CACNA1C | 12 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.451; TCGA BRCA -0.222; TCGA COAD -0.412; TCGA HNSC -0.184; TCGA LIHC -0.485; TCGA LUSC -0.432; TCGA OV -0.184; TCGA PRAD -0.349; TCGA SARC -0.448; TCGA THCA -0.466; TCGA STAD -0.407; TCGA UCEC -0.317 |
hsa-miR-192-5p | KCNB1 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.675; TCGA BRCA -0.469; TCGA COAD -1.006; TCGA ESCA -0.198; TCGA LUAD -0.11; TCGA PAAD -0.318; TCGA PRAD -0.383; TCGA STAD -0.878; TCGA UCEC -0.443 |
hsa-miR-192-5p | GDPD5 | 10 cancers: BLCA; BRCA; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.1; TCGA BRCA -0.206; TCGA KIRP -0.059; TCGA LIHC -0.238; TCGA LUAD -0.062; TCGA OV -0.113; TCGA PAAD -0.115; TCGA PRAD -0.118; TCGA THCA -0.223; TCGA UCEC -0.09 |
hsa-miR-192-5p | KLHL21 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.197; TCGA BRCA -0.131; TCGA CESC -0.23; TCGA COAD -0.101; TCGA ESCA -0.132; TCGA HNSC -0.2; TCGA KIRC -0.156; TCGA LUSC -0.102; TCGA PAAD -0.145; TCGA PRAD -0.117; TCGA SARC -0.221; TCGA STAD -0.199; TCGA UCEC -0.068 |
hsa-miR-192-5p | SDC3 | 13 cancers: BLCA; BRCA; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.188; TCGA BRCA -0.051; TCGA COAD -0.248; TCGA KIRP -0.09; TCGA LGG -0.076; TCGA LIHC -0.351; TCGA LUAD -0.062; TCGA LUSC -0.086; TCGA PAAD -0.121; TCGA PRAD -0.116; TCGA THCA -0.332; TCGA STAD -0.172; TCGA UCEC -0.078 |
hsa-miR-192-5p | ZFYVE1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.071; TCGA BRCA -0.064; TCGA CESC -0.098; TCGA COAD -0.124; TCGA ESCA -0.071; TCGA HNSC -0.103; TCGA LUSC -0.096; TCGA PAAD -0.054; TCGA PRAD -0.051; TCGA SARC -0.063; TCGA STAD -0.106; TCGA UCEC -0.061 |
hsa-miR-192-5p | AMOTL1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.305; TCGA BRCA -0.24; TCGA CESC -0.24; TCGA COAD -0.683; TCGA ESCA -0.218; TCGA HNSC -0.195; TCGA KIRP -0.085; TCGA LUAD -0.053; TCGA OV -0.159; TCGA PAAD -0.286; TCGA SARC -0.179; TCGA THCA -0.117; TCGA STAD -0.437; TCGA UCEC -0.099 |
hsa-miR-192-5p | MECP2 | 9 cancers: BLCA; BRCA; COAD; LIHC; LUAD; PAAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.052; TCGA BRCA -0.07; TCGA COAD -0.053; TCGA LIHC -0.13; TCGA LUAD -0.051; TCGA PAAD -0.081; TCGA SARC -0.07; TCGA STAD -0.154; TCGA UCEC -0.087 |
hsa-miR-192-5p | SHE | 10 cancers: BLCA; BRCA; COAD; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.261; TCGA BRCA -0.386; TCGA COAD -0.51; TCGA LUAD -0.185; TCGA LUSC -0.32; TCGA OV -0.103; TCGA PAAD -0.243; TCGA PRAD -0.109; TCGA STAD -0.188; TCGA UCEC -0.253 |
hsa-miR-192-5p | HSPB7 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -1.069; TCGA BRCA -0.868; TCGA COAD -1.206; TCGA ESCA -0.253; TCGA HNSC -1.12; TCGA KIRC -0.572; TCGA LIHC -0.715; TCGA LUAD -0.138; TCGA LUSC -0.496; TCGA OV -0.157; TCGA PAAD -0.205; TCGA PRAD -0.489; TCGA SARC -0.695; TCGA STAD -0.737; TCGA UCEC -0.508 |
hsa-miR-192-5p | FAM26E | 13 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.439; TCGA BRCA -0.253; TCGA COAD -0.561; TCGA HNSC -0.249; TCGA LIHC -0.304; TCGA LUAD -0.092; TCGA LUSC -0.327; TCGA OV -0.108; TCGA PAAD -0.306; TCGA SARC -0.249; TCGA THCA -0.354; TCGA STAD -0.118; TCGA UCEC -0.207 |
hsa-miR-192-5p | VWA1 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUSC; OV; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.148; TCGA COAD -0.094; TCGA HNSC -0.172; TCGA KIRP -0.156; TCGA LUSC -0.253; TCGA OV -0.127; TCGA PRAD -0.251; TCGA SARC -0.173; TCGA THCA -0.216 |
hsa-miR-192-5p | ARHGEF37 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.313; TCGA BRCA -0.246; TCGA COAD -0.158; TCGA ESCA -0.071; TCGA HNSC -0.254; TCGA LUSC -0.275; TCGA PRAD -0.077; TCGA SARC -0.441; TCGA STAD -0.158; TCGA UCEC -0.102 |
hsa-miR-192-5p | KIRREL | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.454; TCGA BRCA -0.256; TCGA COAD -0.393; TCGA ESCA -0.178; TCGA HNSC -0.395; TCGA LIHC -0.586; TCGA LUAD -0.145; TCGA LUSC -0.256; TCGA OV -0.118; TCGA PAAD -0.364; TCGA THCA -0.322; TCGA STAD -0.152 |
hsa-miR-192-5p | SLIT3 | 12 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.4; TCGA BRCA -0.485; TCGA COAD -0.714; TCGA ESCA -0.074; TCGA LIHC -0.471; TCGA LUAD -0.146; TCGA LUSC -0.433; TCGA OV -0.187; TCGA PAAD -0.37; TCGA PRAD -0.153; TCGA STAD -0.326; TCGA UCEC -0.228 |
hsa-miR-192-5p | ZFP36L1 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.167; TCGA BRCA -0.161; TCGA COAD -0.158; TCGA ESCA -0.133; TCGA HNSC -0.088; TCGA KIRC -0.078; TCGA KIRP -0.058; TCGA LUAD -0.129; TCGA LUSC -0.13; TCGA PAAD -0.197; TCGA PRAD -0.186; TCGA SARC -0.081; TCGA THCA -0.287; TCGA STAD -0.143; TCGA UCEC -0.073 |
hsa-miR-192-5p | TEAD1 | 10 cancers: BLCA; BRCA; COAD; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.102; TCGA COAD -0.138; TCGA LUAD -0.07; TCGA PAAD -0.068; TCGA PRAD -0.167; TCGA SARC -0.129; TCGA THCA -0.137; TCGA STAD -0.277; TCGA UCEC -0.086 |
hsa-miR-192-5p | C15orf52 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.225; TCGA BRCA -0.093; TCGA COAD -0.199; TCGA HNSC -0.358; TCGA KIRC -0.165; TCGA KIRP -0.068; TCGA LIHC -0.435; TCGA LUSC -0.351; TCGA PAAD -0.158; TCGA PRAD -0.125; TCGA SARC -0.725; TCGA STAD -0.439; TCGA UCEC -0.078 |
hsa-miR-192-5p | AFAP1 | 9 cancers: BLCA; COAD; LIHC; LUSC; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.186; TCGA COAD -0.109; TCGA LIHC -0.486; TCGA LUSC -0.103; TCGA OV -0.115; TCGA PAAD -0.104; TCGA SARC -0.153; TCGA STAD -0.141; TCGA UCEC -0.09 |
hsa-miR-192-5p | ADARB1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.332; TCGA BRCA -0.113; TCGA COAD -0.265; TCGA ESCA -0.081; TCGA HNSC -0.084; TCGA KIRP -0.117; TCGA LIHC -0.127; TCGA LUAD -0.108; TCGA LUSC -0.26; TCGA PAAD -0.255; TCGA THCA -0.16; TCGA STAD -0.266; TCGA UCEC -0.122 |
hsa-miR-192-5p | CCDC69 | 10 cancers: BLCA; BRCA; COAD; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.364; TCGA BRCA -0.421; TCGA COAD -0.511; TCGA LUAD -0.06; TCGA LUSC -0.268; TCGA PAAD -0.291; TCGA PRAD -0.39; TCGA SARC -0.359; TCGA STAD -0.413; TCGA UCEC -0.178 |
hsa-miR-192-5p | DOK6 | 10 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.562; TCGA BRCA -0.171; TCGA COAD -0.483; TCGA LIHC -0.308; TCGA LUAD -0.072; TCGA LUSC -0.323; TCGA OV -0.269; TCGA PAAD -0.135; TCGA STAD -0.241; TCGA UCEC -0.244 |
hsa-miR-192-5p | NEURL1B | 10 cancers: BLCA; CESC; ESCA; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.151; TCGA CESC -0.093; TCGA ESCA -0.085; TCGA LUAD -0.119; TCGA PAAD -0.091; TCGA PRAD -0.169; TCGA SARC -0.327; TCGA THCA -0.518; TCGA STAD -0.174; TCGA UCEC -0.159 |
hsa-miR-192-5p | KCTD7 | 11 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.089; TCGA BRCA -0.052; TCGA COAD -0.086; TCGA LIHC -0.139; TCGA LUAD -0.053; TCGA LUSC -0.082; TCGA OV -0.091; TCGA PAAD -0.09; TCGA SARC -0.089; TCGA STAD -0.182; TCGA UCEC -0.106 |
hsa-miR-192-5p | COL5A1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.472; TCGA CESC -0.203; TCGA COAD -0.439; TCGA ESCA -0.139; TCGA HNSC -0.265; TCGA KIRC -0.13; TCGA KIRP -0.177; TCGA LIHC -0.691; TCGA LUAD -0.076; TCGA LUSC -0.331; TCGA OV -0.284; TCGA PAAD -0.317; TCGA THCA -0.824; TCGA UCEC -0.222 |
hsa-miR-192-5p | SLITRK4 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.475; TCGA BRCA -0.264; TCGA CESC -0.272; TCGA ESCA -0.097; TCGA HNSC -0.456; TCGA LUAD -0.183; TCGA OV -0.399; TCGA PAAD -0.415; TCGA PRAD -0.599; TCGA THCA -0.652; TCGA STAD -0.476; TCGA UCEC -0.269 |
hsa-miR-192-5p | ZBTB4 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.127; TCGA BRCA -0.162; TCGA CESC -0.052; TCGA COAD -0.222; TCGA ESCA -0.113; TCGA HNSC -0.099; TCGA KIRC -0.076; TCGA KIRP -0.056; TCGA LIHC -0.272; TCGA LUAD -0.071; TCGA LUSC -0.189; TCGA PAAD -0.102; TCGA PRAD -0.11; TCGA SARC -0.089; TCGA STAD -0.224; TCGA UCEC -0.11 |
hsa-miR-192-5p | PRKG1 | 12 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.639; TCGA BRCA -0.239; TCGA COAD -0.384; TCGA HNSC -0.4; TCGA LIHC -0.363; TCGA LUAD -0.108; TCGA LUSC -0.331; TCGA OV -0.214; TCGA PRAD -0.247; TCGA SARC -0.419; TCGA STAD -0.299; TCGA UCEC -0.301 |
hsa-miR-192-5p | AFAP1L1 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.247; TCGA CESC -0.235; TCGA COAD -0.33; TCGA ESCA -0.122; TCGA HNSC -0.226; TCGA LIHC -0.178; TCGA LUSC -0.28; TCGA PAAD -0.273; TCGA PRAD -0.121; TCGA SARC -0.156; TCGA THCA -0.158; TCGA STAD -0.071; TCGA UCEC -0.155 |
hsa-miR-192-5p | ANO6 | 9 cancers: BRCA; COAD; HNSC; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.154; TCGA COAD -0.13; TCGA HNSC -0.11; TCGA LUSC -0.139; TCGA PRAD -0.228; TCGA SARC -0.078; TCGA THCA -0.19; TCGA STAD -0.11; TCGA UCEC -0.096 |
hsa-miR-192-5p | ARHGAP29 | 9 cancers: BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.106; TCGA COAD -0.276; TCGA KIRC -0.105; TCGA KIRP -0.096; TCGA LUAD -0.13; TCGA LUSC -0.29; TCGA PAAD -0.209; TCGA STAD -0.134; TCGA UCEC -0.126 |
hsa-miR-192-5p | ATRNL1 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.364; TCGA CESC -0.226; TCGA COAD -0.866; TCGA ESCA -0.125; TCGA KIRC -0.327; TCGA KIRP -0.15; TCGA OV -0.237; TCGA PRAD -0.414; TCGA STAD -0.332; TCGA UCEC -0.43 |
hsa-miR-192-5p | CAB39L | 10 cancers: BRCA; KIRC; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.232; TCGA KIRC -0.182; TCGA LIHC -0.168; TCGA LUSC -0.251; TCGA OV -0.158; TCGA PAAD -0.118; TCGA PRAD -0.08; TCGA SARC -0.207; TCGA STAD -0.398; TCGA UCEC -0.194 |
hsa-miR-192-5p | CHST12 | 9 cancers: BRCA; COAD; KIRP; LGG; LIHC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.071; TCGA COAD -0.109; TCGA KIRP -0.052; TCGA LGG -0.147; TCGA LIHC -0.225; TCGA OV -0.073; TCGA PAAD -0.134; TCGA STAD -0.057; TCGA UCEC -0.061 |
hsa-miR-192-5p | ENTPD3 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; OV; PRAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.157; TCGA CESC -0.173; TCGA COAD -0.77; TCGA ESCA -0.276; TCGA KIRC -0.341; TCGA KIRP -0.136; TCGA LIHC -0.515; TCGA LUAD -0.087; TCGA OV -0.194; TCGA PRAD -0.21; TCGA STAD -0.286 |
hsa-miR-192-5p | HAS3 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.423; TCGA CESC -0.515; TCGA ESCA -0.443; TCGA HNSC -0.338; TCGA KIRP -0.181; TCGA LIHC -0.115; TCGA LUAD -0.12; TCGA PRAD -0.193; TCGA SARC -0.213 |
hsa-miR-192-5p | ID1 | 9 cancers: BRCA; CESC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD | miRNAWalker2 validate | TCGA BRCA -0.376; TCGA CESC -0.136; TCGA KIRC -0.076; TCGA KIRP -0.302; TCGA LGG -0.198; TCGA LIHC -0.149; TCGA LUSC -0.147; TCGA OV -0.276; TCGA PRAD -0.406 |
hsa-miR-192-5p | ID4 | 12 cancers: BRCA; COAD; ESCA; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.401; TCGA COAD -0.333; TCGA ESCA -0.136; TCGA KIRP -0.115; TCGA LGG -0.159; TCGA LIHC -0.513; TCGA LUSC -0.301; TCGA PAAD -0.196; TCGA PRAD -0.467; TCGA SARC -0.283; TCGA STAD -0.29; TCGA UCEC -0.2 |
hsa-miR-192-5p | KCNMB4 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUSC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.25; TCGA CESC -0.247; TCGA COAD -0.306; TCGA ESCA -0.111; TCGA KIRC -0.066; TCGA LIHC -0.499; TCGA LUSC -0.229; TCGA PAAD -0.388; TCGA STAD -0.284; TCGA UCEC -0.158 |
hsa-miR-192-5p | LIMCH1 | 10 cancers: BRCA; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; OV; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.125; TCGA COAD -0.351; TCGA HNSC -0.512; TCGA KIRC -0.074; TCGA LIHC -0.442; TCGA LUAD -0.1; TCGA LUSC -0.362; TCGA OV -0.185; TCGA STAD -0.184; TCGA UCEC -0.097 |
hsa-miR-192-5p | PIM1 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.073; TCGA CESC -0.236; TCGA COAD -0.087; TCGA ESCA -0.14; TCGA HNSC -0.241; TCGA KIRC -0.056; TCGA LGG -0.09; TCGA LUSC -0.114; TCGA PAAD -0.171; TCGA PRAD -0.174; TCGA THCA -0.25; TCGA STAD -0.126; TCGA UCEC -0.193 |
hsa-miR-192-5p | SYNGR1 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; OV; UCEC | miRNAWalker2 validate | TCGA BRCA -0.113; TCGA CESC -0.143; TCGA COAD -0.726; TCGA ESCA -0.265; TCGA KIRC -0.192; TCGA KIRP -0.104; TCGA LIHC -0.468; TCGA OV -0.158; TCGA UCEC -0.166 |
hsa-miR-192-5p | VGLL3 | 16 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.317; TCGA CESC -0.247; TCGA COAD -0.767; TCGA ESCA -0.136; TCGA HNSC -0.251; TCGA KIRC -0.268; TCGA LIHC -0.414; TCGA LUAD -0.109; TCGA LUSC -0.517; TCGA OV -0.319; TCGA PAAD -0.452; TCGA PRAD -0.38; TCGA SARC -0.738; TCGA THCA -0.384; TCGA STAD -0.291; TCGA UCEC -0.396 |
hsa-miR-192-5p | ZNF114 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.105; TCGA CESC -0.547; TCGA COAD -0.285; TCGA ESCA -0.393; TCGA HNSC -0.595; TCGA KIRC -0.191; TCGA LGG -0.089; TCGA LUAD -0.13; TCGA LUSC -0.257; TCGA PAAD -0.414; TCGA UCEC -0.143 |
hsa-miR-192-5p | MPPED2 | 10 cancers: BRCA; COAD; ESCA; KIRC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.409; TCGA COAD -0.682; TCGA ESCA -0.219; TCGA KIRC -0.278; TCGA LIHC -0.247; TCGA LUAD -0.129; TCGA PAAD -0.168; TCGA PRAD -0.187; TCGA STAD -0.464; TCGA UCEC -0.286 |
hsa-miR-192-5p | IGF2 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.571; TCGA COAD -0.665; TCGA ESCA -0.095; TCGA HNSC -0.475; TCGA KIRC -0.705; TCGA LUAD -0.141; TCGA OV -0.509; TCGA PAAD -0.33; TCGA PRAD -0.173; TCGA THCA -0.528; TCGA STAD -0.212; TCGA UCEC -0.286 |
hsa-miR-192-5p | NAT8L | 10 cancers: BRCA; COAD; ESCA; KIRC; LIHC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.362; TCGA COAD -0.437; TCGA ESCA -0.125; TCGA KIRC -0.544; TCGA LIHC -0.608; TCGA OV -0.17; TCGA PAAD -0.446; TCGA PRAD -0.179; TCGA THCA -0.471; TCGA STAD -0.235 |
hsa-miR-192-5p | PCDH19 | 9 cancers: BRCA; CESC; ESCA; KIRC; LUAD; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.395; TCGA CESC -0.192; TCGA ESCA -0.433; TCGA KIRC -0.097; TCGA LUAD -0.118; TCGA PAAD -0.383; TCGA THCA -0.312; TCGA STAD -0.326; TCGA UCEC -0.209 |
hsa-miR-192-5p | PHTF2 | 10 cancers: CESC; COAD; ESCA; KIRP; LIHC; LUAD; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.093; TCGA COAD -0.14; TCGA ESCA -0.129; TCGA KIRP -0.084; TCGA LIHC -0.184; TCGA LUAD -0.074; TCGA PAAD -0.211; TCGA THCA -0.052; TCGA STAD -0.109; TCGA UCEC -0.068 |
hsa-miR-192-5p | RHOBTB3 | 10 cancers: CESC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.095; TCGA KIRC -0.308; TCGA KIRP -0.108; TCGA LUAD -0.107; TCGA LUSC -0.149; TCGA OV -0.207; TCGA PAAD -0.257; TCGA THCA -0.249; TCGA STAD -0.195; TCGA UCEC -0.127 |
hsa-miR-192-5p | STK3 | 9 cancers: CESC; ESCA; HNSC; LGG; LIHC; OV; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA CESC -0.057; TCGA ESCA -0.056; TCGA HNSC -0.065; TCGA LGG -0.061; TCGA LIHC -0.087; TCGA OV -0.056; TCGA SARC -0.11; TCGA THCA -0.093; TCGA UCEC -0.109 |
hsa-miR-192-5p | UPP1 | 11 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA CESC -0.147; TCGA ESCA -0.123; TCGA HNSC -0.302; TCGA KIRC -0.094; TCGA KIRP -0.122; TCGA LGG -0.145; TCGA LIHC -0.188; TCGA LUAD -0.051; TCGA LUSC -0.175; TCGA PAAD -0.113; TCGA THCA -0.488 |
hsa-miR-192-5p | NEBL | 9 cancers: CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; UCEC | mirMAP | TCGA CESC -0.189; TCGA ESCA -0.08; TCGA HNSC -0.174; TCGA KIRP -0.13; TCGA LIHC -0.444; TCGA LUAD -0.086; TCGA LUSC -0.197; TCGA PRAD -0.168; TCGA UCEC -0.29 |
hsa-miR-192-5p | N4BP3 | 10 cancers: CESC; COAD; ESCA; KIRC; KIRP; LIHC; OV; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.134; TCGA COAD -0.212; TCGA ESCA -0.062; TCGA KIRC -0.234; TCGA KIRP -0.124; TCGA LIHC -0.438; TCGA OV -0.149; TCGA PRAD -0.096; TCGA THCA -0.242; TCGA STAD -0.157 |
hsa-miR-192-5p | KCNS3 | 9 cancers: COAD; ESCA; KIRC; KIRP; LIHC; LUAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA COAD -0.243; TCGA ESCA -0.229; TCGA KIRC -0.089; TCGA KIRP -0.186; TCGA LIHC -0.33; TCGA LUAD -0.147; TCGA SARC -0.293; TCGA THCA -0.589; TCGA STAD -0.214 |
hsa-miR-192-5p | MEX3B | 10 cancers: COAD; ESCA; KIRC; KIRP; LIHC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.372; TCGA ESCA -0.188; TCGA KIRC -0.075; TCGA KIRP -0.073; TCGA LIHC -0.413; TCGA OV -0.131; TCGA PAAD -0.205; TCGA THCA -0.319; TCGA STAD -0.154; TCGA UCEC -0.209 |
hsa-miR-192-5p | NPTXR | 10 cancers: COAD; ESCA; KIRC; KIRP; LIHC; LUAD; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.595; TCGA ESCA -0.235; TCGA KIRC -0.227; TCGA KIRP -0.104; TCGA LIHC -0.559; TCGA LUAD -0.07; TCGA PAAD -0.31; TCGA THCA -0.39; TCGA STAD -0.43; TCGA UCEC -0.176 |
hsa-miR-192-5p | UBASH3B | 9 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA COAD -0.393; TCGA ESCA -0.07; TCGA HNSC -0.128; TCGA KIRC -0.163; TCGA KIRP -0.255; TCGA LIHC -0.6; TCGA LUSC -0.316; TCGA PAAD -0.245; TCGA THCA -0.17 |
hsa-miR-192-5p | RUNX1 | 11 cancers: COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP; miRNATAP | TCGA COAD -0.2; TCGA ESCA -0.068; TCGA KIRC -0.115; TCGA KIRP -0.308; TCGA LGG -0.179; TCGA LIHC -0.313; TCGA LUAD -0.105; TCGA LUSC -0.135; TCGA PAAD -0.14; TCGA PRAD -0.191; TCGA THCA -0.744 |
hsa-miR-192-5p | ORAI2 | 9 cancers: COAD; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | mirMAP | TCGA COAD -0.151; TCGA KIRP -0.09; TCGA LGG -0.081; TCGA LIHC -0.542; TCGA LUAD -0.071; TCGA LUSC -0.1; TCGA OV -0.088; TCGA PAAD -0.185; TCGA THCA -0.162 |
Enriched cancer pathways of putative targets